Stock listing
Actinogen Medical Limited
Selected listing: 3AC · FWB · EUR · DE
Actinogen Medical Limited (Frankfurt:3AC), Health Technology. Latest release Sep 23, 2026: Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final…
- Ticker
- Frankfurt:3AC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- Frankfurt
- Currency
- EUR
About Actinogen Medical Limited
The company focuses on developing innovative treatments for cognitive disorders. Actinogen is committed to advancing its research and clinical programs to address significant unmet medical needs in this area.
Latest news from Actinogen Medical Limited
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November
September 23, 2026
Underwriting of unlisted options completed
September 22, 2026
ACW unlisted options fully underwritten
August 31, 2026
ACW FY2026 results and outlook
August 27, 2026
June 2026 Quarterly activity report & Appendix 4C
July 29, 2026
Research Actinogen Medical Limited
Actinogen Medical Limited company profile
View the public company page for Actinogen Medical Limited on 6ix.
Actinogen Medical Limited news
Read company news and market updates connected to Actinogen Medical Limited.
Actinogen Medical Limited investor events
Find investor webinars, events, and replay context for Actinogen Medical Limited.
Alternate listings
ACW:ASX
AU · AUD
Alternate listing for Actinogen Medical Limited; the primary context on this page is 3AC:FWB.
ATGGF:OTC
US · USD
Alternate listing for Actinogen Medical Limited; the primary context on this page is 3AC:FWB.
A0MZH8:LS
DE · EUR
Alternate listing for Actinogen Medical Limited; the primary context on this page is 3AC:FWB.